|
|
| Maladies Infectieuses > Etude de marché sectorielle |
| The Vaccines Market Outlook: Market analysis of future growth and leading players by sector |
|
|
|
|
€ 2 443,75 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2005 |
Taille du document : |
122 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 48 pages | Mars 1999 | Anglais
|
|
|
| Main
focus: |
vaccines,vaccine,hepatitis b,immunology,...,...
|
| Research
focus: |
market outlook,demand analysis,industry structure, |
| Geographic
focus: |
usa,france,united kingdom,canada,switzerland,japan,... |
| |
|
|
|
|
| 118 pages | Décembre 2002 | Anglais
|
|
|
| Main
focus: |
health care,vaccines,vaccine,hepatitis b,...
|
| Research
focus: |
industry structure,market definition, |
| Geographic
focus: |
india,usa,switzerland,france,united kingdom,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Therapeutic Vaccines: More Trials and Tribulations
202 pages | Décembre 2005 |
IntroductionTherapeutic vaccines have faced numerous setbacks in recent years.
The only three vaccines to reach the market have had insignificant sales, while the pipeline has seen numerous high-pr |
6 460,00 €
|
| |
| |
Stakeholder Perspectives: Influenza Vaccines - Flying back Into Flu
166 pages | Décembre 2005 |
IntroductionInfluenza is a highly infectious disease which globally infects 10-20% of the population every year causing up to 500,000 deaths.
Although all persons are at risk, the elderly and the y |
6 460,00 €
|
| |
| |
Lower Detection Limits of HBV DNA Assays
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
The Antivirals Market Outlook: Market analysis of future growth and leading players by sector
178 pages | Janvier 2005 |
Business Insights have teamed up with IMS Health to bring you, ‘The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an |
2 443,75 €
|
| |
| |
Human Vaccines
481 pages | Octobre 2005 |
This report analyzes the worldwide markets for Human Vaccines in Millions of US$.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Jap |
3 091,00 €
|
| |
| |
Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution
237 pages | Avril 2005 |
IntroductionLess than 50% of chronically infected hepatitis C patients do not benefit from the current standard of care, pegylated interferon plus ribavirin.
In the short-term, the treatment landsc |
9 120,00 €
|
| |
| |
Monoclonal Antibody Therapies: Evolving into a $30 billion market
360 pages | Avril 2005 |
IntroductionThe monoclonal antibody market is one of the fastest growing and most lucrative sectors of the pharmaceutical industry, with exceptional 48.1% growth between 2003 and 2004.
It has the p |
12 160,00 €
|
| |
| |
Antiviral HIV Treatment in Developing Countries Number of Patients
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Pipeline Insight: Hematological malignancies - Targeted treatments and immunotherapy infuse new blood
219 pages | Avril 2005 |
IntroductionGiven an enhanced understanding of the biological basis for oncogenesis and the benefit of immunotherapy approaches such as Genentech/Roche's Rituxan, it is no surprise that targeted treat |
9 120,00 €
|
| |
| |
Pipeline Insight: HIV - Hold Your Horses
216 pages | Avril 2005 |
IntroductionIn the current antiretroviral landscape, resistance in all three of the established classes is proving to be problematic.
Accordingly, current clinical trials are recruiting treatment-r |
9 120,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| The Vaccines Market Outlook: Market analysis of future growth and leading players by sector |
|
|
Business Insights have teamed up with IMS Health to bring you, ‘The Vaccines Market Outlook: Market analysis of future growth and leading players by sector.’ This unique report provides unrivalled analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, and also includes company reported sales data allowing you to spot any discrepancies between the two sets of data. Refresh your vaccines strategy with unrivalled analysis The Vaccines Market Outlook: Market analysis of future growth and leading players by sector provides a detailed analysis of the vaccines market in the US and the five major European markets. The market for vaccines is broken down by population (pediatric and adult) and also by disease area. A comprehensive competitive overview is provided with an examination of key brands together with profiles of the leading players in this market. This new report also reviews some of the most promising products in development, highlighting those expected to drive market growth in the future and in some cases become the first vaccine to market for a disease. Adult and travel vaccine segments are likely to drive growth in the future, use this latest vaccines report to discover the latest products which are set to transform this market.
|
|
Business Insights have teamed up with IMS Health to bring you, ‘The Vaccines Market Outlook: Market analysis of future growth and leading players by sector.’ This unique report provides unrivalled analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, and also includes company reported sales data allowing you to spot any discrepancies between the two sets of data. Refresh your vaccines strategy with unrivalled analysis The Vaccines Market Outlook: Market analysis of future growth and leading players by sector provides a detailed analysis of the vaccines market in the US and the five major European markets. The market for vaccines is broken down by population (pediatric and adult) and also by disease area. A comprehensive competitive overview is provided with an examination of key brands together with profiles of the leading players in this market. This new report also reviews some of the most promising products in development, highlighting those expected to drive market growth in the future and in some cases become the first vaccine to market for a disease. Adult and travel vaccine segments are likely to drive growth in the future, use this latest vaccines report to discover the latest products which are set to transform this market.
|
|
|
PPLSEN
|
|
|
|
|
